MicroRNA-338-3p as a therapeutic target in cardiac fibrosis through FGFR2 suppression.
Huang C, Wang R, Lu J, He Y, Wu Y, Ma W, Xu J, Wu Z, Feng Z, Wu M.
Huang C, et al. Among authors: wu y, wu m, wu z.
J Clin Lab Anal. 2022 Aug;36(8):e24584. doi: 10.1002/jcla.24584. Epub 2022 Jul 6.
J Clin Lab Anal. 2022.
PMID: 35792028
Free PMC article.